Top Biotechnology companies in United States by Operating Income

This ranking features the top 520 Biotechnology companies in United States ranked by Operating Income, totalling a Operating Income of USD 36.56 B, for January 15, 2025.

United States

Biotechnology

#	Name	Operating Income	Reported Date	Stock Price	Change	Country
1	AbbVie Inc. 1 ABBV	USD 13.82 B	Sept. 30, 2024	USD 175.55	-0.67%	United States
2	Bristol-Myers Squibb Company 2 BMY	USD 10.31 B	Sept. 30, 2024	USD 55.74	0.69%	United States
3	Pfizer Inc. 3 PFE	USD 10.13 B	Sept. 29, 2024	USD 26.41	-1.46%	United States
4	Gilead Sciences, Inc. 4 GILD	USD 8.38 B	Sept. 30, 2024	USD 91.00	1.18%	United States
5	Thermo Fisher Scientific Inc. 5 TMO	USD 7.17 B	Sept. 28, 2024	USD 556.99	0.27%	United States
6	Amgen Inc. 6 AMGN	USD 6.11 B	Sept. 30, 2024	USD 267.10	-1.14%	United States
7	Stryker Corporation 7 SYK	USD 4.48 B	Sept. 30, 2024	USD 362.80	0.50%	United States
8	Regeneron Pharmaceuticals, Inc. 8 REGN	USD 4.00 B	Sept. 30, 2024	USD 690.87	-3.63%	United States
9	Danaher Corporation 9 DHR	USD 3.98 B	Sept. 27, 2024	USD 237.62	-0.94%	United States
10	Zoetis Inc. 10 ZTS	USD 3.34 B	Sept. 30, 2024	USD 164.41	-1.15%	United States
11	IQVIA Holdings Inc. 11 IQV	USD 2.18 B	Sept. 30, 2024	USD 197.96	-3.26%	United States
12	Biogen Inc. 12 BIIB	USD 1.99 B	Sept. 30, 2024	USD 143.06	-4.74%	United States
13	Corteva, Inc. 13 CTVA	USD 1.96 B	Sept. 30, 2024	USD 60.89	1.60%	United States
14	Royalty Pharma plc 14 RPRX	USD 1.54 B	Sept. 30, 2024	USD 30.03	0.13%	United States
15	Agilent Technologies, Inc. 15 A	USD 1.50 B	Oct. 31, 2024	USD 143.43	1.04%	United States
16	United Therapeutics Corporation 16 UTHR	USD 1.28 B	Sept. 30, 2024	USD 364.70	0.50%	United States
17	Laboratory Corporation of America Holdings 17 LH	USD 1.12 B	Sept. 30, 2024	USD 234.50	0.17%	United States
18	Illumina, Inc. 18 ILMN	USD 1.11 B	Sept. 29, 2024	USD 136.48	-5.37%	United States
19	Avantor, Inc. 19 AVTR	USD 662.90 M	Sept. 30, 2024	USD 21.72	-1.36%	United States
20	DexCom, Inc. 20 DXCM	USD 628.00 M	Sept. 30, 2024	USD 79.17	-0.84%	United States
21	Charles River Laboratories International, Inc. 21 CRL	USD 562.91 M	Sept. 28, 2024	USD 178.08	-6.34%	United States
22	Exelixis, Inc. 22 EXEL	USD 523.67 M	Sept. 27, 2024	USD 35.65	0.99%	United States
23	Halozyme Therapeutics, Inc. 23 HALO	USD 477.01 M	Sept. 30, 2024	USD 53.83	-0.57%	United States
24	Lantheus Holdings, Inc. 24 LNTH	USD 474.24 M	Sept. 30, 2024	USD 92.62	-2.15%	United States
25	Summit Therapeutics Inc. 25 SMMT	USD 468.47 M	Sept. 30, 2023	USD 16.65	-8.42%	United States
26	Sotera Health Company 26 SHC	USD 349.92 M	Sept. 30, 2024	USD 12.76	-2.52%	United States
27	Bruker Corporation 27 BRKR	USD 328.40 M	Sept. 30, 2024	USD 61.26	-2.69%	United States
28	Revvity, Inc. 28 RVTY	USD 320.95 M	Sept. 29, 2024	USD 120.73	-1.61%	United States
29	Bio-Rad Laboratories, Inc. 29 BIO	USD 314.56 M	Sept. 30, 2024	USD 342.23	-2.69%	United States
30	BioMarin Pharmaceutical Inc. 30 BMRN	USD 313.43 M	Sept. 30, 2024	USD 63.81	-4.75%	United States
31	Bio-Techne Corporation 31 TECH	USD 228.96 M	Sept. 30, 2024	USD 74.73	-2.21%	United States
32	Amphastar Pharmaceuticals, Inc. 32 AMPH	USD 214.25 M	Sept. 30, 2024	USD 38.48	1.48%	United States
33	Balchem Corporation 33 BCPC	USD 195.82 M	Sept. 30, 2024	USD 158.62	1.47%	United States
34	Harmony Biosciences Holdings, Inc. 34 HRMY	USD 175.29 M	Sept. 30, 2024	USD 36.42	-0.08%	United States
35	Catalyst Pharmaceuticals, Inc. 35 CPRX	USD 173.97 M	Sept. 30, 2024	USD 22.19	-0.09%	United States
36	Globus Medical, Inc. 36 GMED	USD 164.47 M	Sept. 30, 2024	USD 88.18	1.15%	United States
37	Protagonist Therapeutics, Inc. 37 PTGX	USD 149.11 M	Sept. 30, 2024	USD 36.67	-1.26%	United States
38	Corcept Therapeutics Incorporated 38 CORT	USD 143.36 M	Sept. 30, 2024	USD 51.66	1.18%	United States
39	ADMA Biologics, Inc. 39 ADMA	USD 114.89 M	Sept. 30, 2024	USD 16.32	-1.03%	United States
40	ACADIA Pharmaceuticals Inc. 40 ACAD	USD 112.23 M	Sept. 30, 2024	USD 16.90	-5.59%	United States
41	Ironwood Pharmaceuticals, Inc. 41 IRWD	USD 108.55 M	Sept. 30, 2024	USD 3.65	-3.18%	United States
42	SIGA Technologies, Inc. 42 SIGA	USD 104.57 M	Sept. 30, 2024	USD 6.33	4.46%	United States
43	Sarepta Therapeutics, Inc. 43 SRPT	USD 81.03 M	Sept. 30, 2024	USD 118.83	0.34%	United States
44	MiMedx Group, Inc. 44 MDXG	USD 74.75 M	Sept. 30, 2024	USD 8.61	0.58%	United States
45	Entrada Therapeutics, Inc. 45 TRDA	USD 57.78 M	Sept. 30, 2024	USD 12.49	-6.58%	United States
46	MannKind Corporation 46 MNKD	USD 54.80 M	Sept. 30, 2024	USD 6.03	-1.63%	United States
47	First Advantage Corporation 47 FA	USD 47.67 M	Sept. 30, 2024	USD 17.21	-1.54%	United States
48	Artivion, Inc. 48 AORT	USD 41.13 M	Sept. 30, 2024	USD 29.68	1.16%	United States
49	Krystal Biotech, Inc. 49 KRYS	USD 39.95 M	Sept. 30, 2024	USD 142.64	-5.10%	United States
50	biote Corp. 50 BTMD	USD 38.91 M	Sept. 30, 2024	USD 5.67	2.35%	United States

1 2 3 4 … 11

Frequently Asked Questions

Which Biotechnology company in United States has the highest Operating Income ?

The Biotechnology company in United States with the highest Operating Income is AbbVie Inc. (NYSE: ABBV) at USD 13.82 B.
Which Biotechnology company in United States has the lowest Operating Income ?

The Biotechnology company in United States with the lowest Operating Income is Moderna, Inc. (NasdaqGS: MRNA) at USD -2.69 B.

What are the top 10 Biotechnology companies in United States by Operating Income ?

The top 10 Biotechnology companies in United States by Operating Income are AbbVie Inc., Bristol-Myers Squibb Company, Pfizer Inc., Gilead Sciences, Inc., Thermo Fisher Scientific Inc., Amgen Inc., Stryker Corporation, Regeneron Pharmaceuticals, Inc., Danaher Corporation and Zoetis Inc..
What are the bottom 10 Biotechnology companies in United States by Operating Income ?

The bottom 10 Biotechnology companies in United States by Operating Income are Moderna, Inc., GRAIL, LLC, MediciNova, Inc., Biohaven Pharmaceutical Holding Company Ltd., Insmed Incorporated, Tempus AI, Inc., Revolution Medicines, Inc., Arrowhead Pharmaceuticals, Inc., Ginkgo Bioworks Holdings, Inc. and Madrigal Pharmaceuticals, Inc..